Open AccessCo-administration of GnRH agonists with vaginal progesterone compared to vaginal progesterone in luteal phase support of the frozen-thawed embryo transfer cycle: An RCT
Author(s) -
Afsoon Zareii,
Sara Davoodi,
Mahshid Alborzi,
Marzieh Eslami Moghadam,
Elham Askary
Publication year - 2021
Publication title -
international journal of reproductive biomedicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.445
H-Index - 29
eISSN - 2476-4108
pISSN - 2476-3772
DOI - 10.18502/ijrm.v19i10.9817
Subject(s) - luteal phase , embryo transfer , medicine , hormone antagonist , pregnancy , pregnancy rate , andrology , gynecology , hormone , endocrinology , biology , endocrine system , genetics
Since progesterone alone does not seem to be enough for luteal phase support (LPS), especially in frozen embryo transfer (FET) cycles, so gonadotropin-releasing hormone agonist (GnRH-a) is suggested as an adjuvant therapy in combination with progesterone for LPS.